Must-Reads Of The Week From Brianna Labuskes
Newsletter editor Brianna Labuskes wades through hundreds of health care policy stories each week, so you don't have to.
Drugs
781-800 of 1,314 results
-
-
KHN鈥檚 鈥榃hat The Health?鈥: Could The ACA Really Go Away?
Is the entire Affordable Care Act unconstitutional? That was the question before a federal appeals court in New Orleans this week. Two of the three judges on the panel seemed inclined to agree with a lower court that the elimination of the tax penalty for failure to maintain coverage could mean the entire health law should fall. Also this week, President Donald Trump wants to improve care for people with kidney disease. Joanne Kenen of Politico, Kimberly Leonard of the Washington Examiner and Alice Miranda Ollstein of Politico join KHN鈥檚 Julie Rovner to discuss this, plus courts blocking efforts to require drug prices in TV ads and to kick Planned Parenthood out of the federal family planning program. Plus, Rovner interviews University of Michigan law professor Nicholas Bagley about the latest legal threat to the ACA.
-
How To Get A Cheaper Prescription Before Leaving The Doctor鈥檚 Office
A pricing tool embedded in their electronic health record and prescribing system lets doctors see how much patients will pay out-of-pocket based on their insurance and the pharmacy. But doctors have been slow to adopt the technology, which has limitations.
-
Watch: High Cost Of Insulin Sends Americans To Canada To Stock Up
KHN, in collaboration with PBS NewsHour, reports on the skyrocketing cost of insulin 鈥 and the trend's deadly consequences. The price in the U.S. nearly doubled from 2012 to 2016, prompting some patients and activists to travel to Canada, where insulin can be 90% cheaper.
By Sarah Varney -
Must-Reads Of The Week From Brianna Labuskes
Newsletter editor Brianna Labuskes wades through hundreds of health care policy stories each week, so you don't have to.
-
Pelosi Aims For Feds To Negotiate Drug Prices, Even For Private Insurers
A draft plan spearheaded by House Speaker Nancy Pelosi would allow the federal government for the first time to negotiate prices for 250 drugs for Medicare and apply those prices to all payers, including employers and insurers.
-
Trump Has Blessed States鈥 Exploration Of Importing Drugs. Will It Catch On?
Colorado, Florida and Vermont 鈥 with the support of President Donald Trump 鈥 are exploring plans to bring drugs across the border from Canada to help lower costs.
-
KHN鈥檚 鈥榃hat The Health?鈥: Dems Debate Health Care
Democratic presidential candidates disagreed on how to fix health care in their first debate Wednesday, although they all called for boosting insurance coverage and lowering prices. Meanwhile, the Trump administration is keeping health care in the news, too, with a new plan to make medical prices more available to the public. Stephanie Armour of The Wall Street Journal, Rebecca Adams of CQ Roll Call and Anna Edney of Bloomberg News join KHN鈥檚 Julie Rovner to discuss this, plus the latest in news about bipartisan progress on catch-all legislation to address 鈥渟urprise鈥 medical bills. Plus, Rovner interviews NPR鈥檚 Jon Hamilton about the latest KHN-NPR 鈥淏ill of the Month鈥 installment.
-
How Black Pharmacists Are Closing The Cultural Gap In Health Care
Independent black-owned pharmacies fill a void for African American patients looking for care that鈥檚 sensitive to their heritage, beliefs and values.
By Cara Anthony -
鈥楢n Arm And A Leg鈥: Why Are Drug Prices So Random? Meet Mr. PBM
Beware at the pharmacy counter: Your insurance company could be in cahoots with a pharmacy benefit manager 鈥 and the negotiations that go on between them are trade secrets.
-
Middlemen Who Save $$ On Medicines 鈥 But Maybe Not For You
Guess who鈥檚 back grabbing headlines? Pharmacy benefit managers 鈥 those companies that serve as middlemen in the prescription drug pipeline.
-
The Values Of Health Care
Julie Rovner, the chief Washington correspondent for Kaiser Health News, joins Margot Sanger-Katz of The New York Times, Joanne Kenen of Politico and Alan Weil of Health Affairs at the Aspen Ideas: Health festival to discuss how consumers鈥 values impact the politics surrounding the national debate on health care.
-
KHN鈥檚 鈥榃hat The Health鈥: Politics Heading Into 2020: Live From Aspen!
How big an issue will health really be in the 2020 election? Will the Republicans find their political footing on the issue? In this episode of KHN鈥檚 鈥淲hat the Health?鈥 Julie Rovner of Kaiser Health News, Joanne Kenen of Politico and Margot Sanger-Katz of The New York Times report from the Aspen Ideas: Health festival in Aspen, Colo. Joining them are Chris Jennings, who advised Democratic Presidents Bill Clinton and Barack Obama on health policy, and Lanhee Chen, who advised GOP presidential candidates Mitt Romney and Marco Rubio.
-
Non-English Speakers Face Health Setback If Trump Loosens Language Rules
A rule proposed by the Trump administration would leave patients with limited English proficiency with fewer guarantees of a written notice that free translation services are available. It also would no longer require directions on how patients can report discrimination they experience in a medical setting.
-
Must-Reads Of The Week From Brianna Labuskes
Newsletter editor Brianna Labuskes wades through hundreds of health care policy stories each week, so you don't have to.
-
Surgeons鈥 Opioid-Prescribing Habits Are Hard To Kick
A new data analysis by KHN and Johns Hopkins researchers shows that even as the CDC issued warnings, surgeons handed out many times the number of opioid pills needed for post-op pain.
By Julie Appleby and Elizabeth Lucas -
Opioid Operators: How Surgeons Ply Patients With Painkillers
Even as awareness of the opioid crisis grew, prescribing habits of surgeons changed very little from 2011 to 2016, found a data analysis by KHN and Johns Hopkins Bloomberg School of Public Health. Use this interactive tool to search by doctor or practicing hospital.
-
Must-Reads Of The Week From Brianna Labuskes
Newsletter editor Brianna Labuskes wades through hundreds of health care policy stories each week, so you don't have to.
-
FDA Overlooked Red Flags In Drugmaker鈥檚 Testing of New Depression Medicine
In March, a chemical cousin of the anesthetic and club drug ketamine was approved for the treatment of patients with intractable depression. But critics say studies presented to the FDA provided at best modest evidence it worked and did not include information about the safety of the drug, Spravato, for long-term use.
-
Must-Reads Of The Week From Brianna Labuskes
Newsletter editor Brianna Labuskes wades through hundreds of health care policy stories each week, so you don't have to.